# Study Comparing Doses Of An Experimental Glucocorticoid Compound To Prednisone And Placebo In Rheumatoid Arthritis

> **NCT01393639** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 323 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** PF-04171327
- **DRUG:** PF-04171327
- **DRUG:** PF-04171327
- **DRUG:** PF-04171327
- **DRUG:** prednisone
- **OTHER:** prednisone
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT01393639
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09-27
- **Primary completion:** 2014-06-03
- **Final completion:** 2014-06-09
- **Target enrollment:** 323 (ACTUAL)
- **Last updated:** 2024-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01393639

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01393639, "Study Comparing Doses Of An Experimental Glucocorticoid Compound To Prednisone And Placebo In Rheumatoid Arthritis". Retrieved via AI Analytics 2026-09-28 from https://api.ai-analytics.org/clinical/NCT01393639. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*